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Abstract
Background
Intrauterine growth restriction (IUGR) results from a lack of nutrients transferred to the
developing fetus, particularly oxygen and glucose. Increased expression of the cytoprotec-
tive mitochondrial peptide, humanin (HN), and the glucose transporter 8, GLUT8, has been
reported under conditions of hypoxic stress. However, the presence and cellular localization
of HN and GLUT8 in IUGR-related placental pathology remain unexplored. Thus, we under-
took this study to investigate placental expression of HN and GLUT8 in IUGR-affected ver-
sus normal pregnancies.
Results
We found 1) increased HN expression in human IUGR-affected pregnancies on the mater-
nal aspect of the placenta (extravillous trophoblastic (EVT) cytoplasm) compared to control
(i.e. appropriate for gestational age) pregnancies, and a concomitant increase in GLUT8
expression in the same compartment, 2) HN and GLUT8 showed a protein-protein interac-
tion by co-immunoprecipitation, 3) elevated HN and GLUT8 levels in vitro under simulated
hypoxia in human EVT cells, HTR8/SVneo, and 4) increased HN expression but attenuated
GLUT8 expression in vitro under serum deprivation in HTR8/SVneo cells.
Conclusions
There was elevated HN expression with cytoplasmic localization to EVTs on the maternal
aspect of the human placenta affected by IUGR, also associated with increased GLUT8
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expression. We found that while hypoxia increased both HN and GLUT8, serum deprivation
increased HN expression alone. Also, a protein-protein interaction between HN and GLUT8
suggests that their interaction may fulfill a biologic role that requires interdependency.
Future investigations delineating molecular interactions between these proteins are required
to fully uncover their role in IUGR-affected pregnancies.
Introduction
Intrauterine growth restriction (IUGR) results from the inability of the fetus to reach its full
growth potential due to conditions that impede normal achievement of expected weight for
any gestational age. IUGR is traditionally defined as an estimated fetal weight (EFW) less than
10th percentile for gestational age and sex, however, this definition includes normally grown
but “constitutionally” small fetuses. Distinguishing between normal and pathological growth is
essential in clinical practice, as IUGR is the second leading cause of perinatal morbidity and
mortality worldwide, and has important implications for adverse endocrine function and
metabolism throughout life [1]. The pathogenesis of IUGR is poorly understood, but is
thought to involve placental insufficiency with concomitant disruption of nutrient supply, the
redox balance, and energy metabolism [2, 3].
Although hypoxia regulates the physiological development of human embryos, persistent
hypoxia presents a significant stress to the growing fetus [4]. Based on studies demonstrating
its cytoprotective role in diseases related to persistent hypoxia, we hypothesized that humanin
peptide (HN) may be important in mediating such stress in IUGR [5–8]. Originally described
by several groups [9–12], HN is a small, endogenous peptide that is putatively encoded within
the open reading frame of the 16S rRNA of the mitochondrial genome. Since its discovery, HN
has shown to provide cytoprotection against various cell stressors in several organ systems[12].
We have demonstrated that treating mitochondria, a major source of reactive oxygen species,
with HN reduced H2O2 production over 50%, supporting a direct role for HN in reduction of
mitochondrial oxidative stress[8]. Other studies have also shown that addition of exogenous
HN under a number of oxidative stress-associated conditions to be cytoprotective[5–8].
Multiple studies of humanin expression in skeletal muscle suggest that humanin expression
may be up regulated in conditions of oxidative stress as a physiological response to cope with
defects in mitochondrial energy production[13]. In addition to its cytoprotective/anti-apopto-
tic role, HN has been linked to glucose homeostasis by improving glucose-stimulated insulin
secretion and peripheral insulin signaling [14]. Recently, serum humanin concentrations were
found to be increased in women affected by preeclampsia [15]. Given the increased levels of
HN [16] and GLUT8 [17] under conditions of oxidative stress observed in non-placental sys-
tems, and the intracellular localization of both, we hypothesized that there may be a similar
expression profile of HN and GLUT8 in the placenta, and that expression of these may be
altered in pregnancy affected by IUGR.
Glucose is a critical nutrient for the fetus, relying on transport at the maternal-fetal inter-
face. Perturbations in this transport system also contribute towards the development of IUGR.
There are 14 known isoforms of the membrane-spanning glucose transporter (GLUT) family,
which are responsible for facilitated diffusion of glucose across the lipid bilayers of cell mem-
branes [18]. Several members of the GLUT family, including GLUT1 [19, 20], GLUT3 [21–
23], GLUT4 [24], and GLUT8 [25] are expressed by the human placental trophoblasts during
pregnancy. In a previous study, we found chronic hypoxia plays a critical role in altered
HN and GLUT8 in IUGR
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placental GLUTs [26]. While no changes in GLUT1 and GLUT4 were seen, the expression of
the plasma membrane associated GLUT3 was increased in trophoblasts on the maternal face
of the term placenta in IUGR compared to normal, appropriate for gestational age term pla-
centa. This elevation was associated with increased nuclear concentration of HIF-1α, suggest-
ing that hypoxia may play a role in up-regulating GLUT3. However, GLUT8, a related isoform
also expressed in the placenta with an intracellular localization [27], has not been examined so
far in the human IUGR term placenta.
Here, we describe HN and GLUT8 for the first time in IUGR-affected placentas and the
expression of these proteins in placentas from IUGR-affected versus normal pregnancies.
Materials and methods
Placental clinical characteristics and tissue collection
Our study protocol was approved by The University of California, Los Angeles (UCLA) Insti-
tutional Review Board (IRB). For participation in this study, subjects provided consents for
use of study samples for research and use of their medical records. After informed consent
was obtained, placentas were collected at the time of delivery at the UCLA Labor and Delivery
Unit. Twenty-two placentas were collected from normal term births, and twenty-two placentas
were from term IUGR births [28] (birth weight less than the 10th percentile) that demonstrated
a trajectory of fetal growth deceleration in utero, diagnosed by prenatal ultrasound [29]. To
meet criteria for eligibility in this study, subjects whose pregnancies were complicated by idio-
pathic, uncomplicated IUGR were included (we did not include cases that had additional clini-
cal complications; thus these subjects did not have preeclampsia, diabetes, or other significant
co-morbidities). The maternal age, gestational age at delivery, placental weight, birth weight,
baby sex, and delivery modes are in Table 1.
Detailed characteristics of the IUGR patients are in Table 2. Fifteen out of twenty-two
IUGR babies were asymmetrically grown (Table 2). Asymmetric IUGR was defined by birth
weight less than length and/or head circumference percentiles when the weight percentile was
two percentile categories below length and/or head circumference [30].
A cross-section of placental tissue was obtained at the insertion of the umbilical cord. The
amnion membrane was peeled off the cross-sectional placental slice and the tissue washed in
ice-cold 1x phosphate-buffered saline (PBS) to remove maternal blood. Fetal placental samples
were obtained from the area close to the amnion. Maternal samples were collected from the
basal plate after the decidual layer was removed by sharp dissection as previously described
[26]. One set of samples was snap-frozen in liquid nitrogen and stored at -80˚C, and another
set of samples was formalin-fixed for immunohistochemical analysis.
Table 1. Clinical characteristics of control and affected groups. Values are ±SEM. Statistical significance was assigned at p<0.05 using Student’s t-test.
Normal Pregnancy IUGR-Affected Pregnancy P-Value
n = 22 22
Maternal Age at Delivery (Years) 32.227 ± 1.369 29.727 ± 1.043 0.085
Gestational Age at Delivery (Weeks) 39.104 ± 0.223 38.054 ± 0.387 0.026
Placental Weight (Grams) 646.252 ± 39.25 414.601 ± 24.991 <0.001
Birth Weight (Grams) 3361.182 ± 62.084 2450.895 ± 66.019 <0.001
Baby Sex 9 females, 13 males 9 females, 13 males
Delivery Mode 16 c/s, 6 NSVD 7 c/s, 15 NSVD
 = p<0.05.
IUGR-affected pregnancy parameters were statistically different from their corresponding normal groups.
https://doi.org/10.1371/journal.pone.0193583.t001
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In vitro trophoblast cell studies
Trophoblast cell culture and treatment. We obtained the human extravillous tropho-
blast (EVT) cell line, HTR8/SVneo, developed by Dr. Charles Graham (Queens University,
Kingston, ON, Canada) [31] as a gift provided by Dr. Ravi Javeri at Duke University Medical
Center. Gibco reagents (Life Technologies, NY) were used for cell culture studies. Cells were
Table 2. Clinical characteristics of IUGR cases.
Birth
weight,
gm
Percentile
(%)
Gestational
age (wk)
Length
(cm)
Percentile
(%)
Head
circumference
(cm)
Percentile
(%)
Growth
profile
Adverse outcome due to IUGR
Antenatal Postnatal
1 2240 <3 39+2 46 3 33.5 20 asymmetrical 1. AC (<3%) 2. Abnormal
Dopplers
-NICU
admission
2 1865 3 35+4 44.5 20 29.5 10 asymmetrical 1. AC (<5%) 2. Abnormal
Dopplers 3.
Oligohydramnios
-NICU
admission
3 2240 3 35+5 46 10 31 7 asymmetrical -Fetal growth deceleration -NICU
admission
4 2190 3 37+6 47.3 15 30.5 3 asymmetrical -C/S for fetal distress -NICU
admission
5 2300 3 38+1 45.5 3 33 30 asymmetrical -Fetal growth deceleration
6 2495 7 38+1 47 10 30.5 3 asymmetrical -Fetal growth deceleration -NICU
admission
7 2645 7 39 49 30 32.5 10 asymmetrical 1. Fetal growth deceleration
2. Abnormal Dopplers
8 2552 7 38+2 50 50 33 20 asymmetrical -Fetal growth deceleration -NICU
admission
9 2475 8 37+3 48.3 45 33 30 asymmetrical 1. Fetal growth deceleration
2. Abnormal Dopplers
10 2560 8 38 51.4 80 33.5 40 asymmetrical 1. Fetal growth deceleration
2. Abnormal Dopplers
-NICU
admission
11 2890 8 40+3 50.8 40 33.7 10 asymmetrical 1. Fetal growth deceleration
2. Abnormal Dopplers
-NICU
admission
12 2535 10 37+4 48.9 50 32.4 30 asymmetrical -Fetal growth deceleration
13 2980 10 40+1 50.8 40 30.5 <3 asymmetrical 1. AC (<3%) 2. Fetal
growth deceleration 3.
Abnormal Dopplers
-NICU
admission
14 2675 10 37+4 49.5 50 33.7 50 asymmetrical -Fetal growth deceleration 1. NICU
admission 2.
Fetal CHD
15 1920 10 34+2 40.5 3 31 30 asymmetrical -Fetal growth deceleration -NICU
admission
16 2580 2 40+3 46.5 3 31 <3 symmetrical -C/S for fetal distress -NICU
admission
17 2840 3 41+2 48.4 7 33.2 7 symmetrical -Fetal growth deceleration -NICU
admission
18 2690 7 39+3 48.3 10 31.8 3 symmetrical -NICU
admission
19 2460 7 37+6 43.2 <3 30.5 3 symmetrical 1. Fetal growth deceleration
2. Abnormal Dopplers
-NICU
admission
20 2608 7 39 44.5 <3 33 10 symmetrical -Fetal growth deceleration
21 1860 7 35 44 10 29.9 9 symmetrical 1. AC (<3%) 2. Abnormal
Dopplers 3.
Oligohydramnios
-NICU
admission
22 2320 9 36+5 45.3 10 32.3 25 symmetrical 1. Fetal growth deceleration
2. Abnormal Dopplers
-NICU
admission
https://doi.org/10.1371/journal.pone.0193583.t002
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cultured in a gas mixture of 5% CO2-95% air at 37˚C in RPMI 1640 medium with L-glutamine
and 25 mM HEPES and 5% penicillin-streptomycin supplemented with 10% fetal bovine
serum (FBS), and were passaged using 0.25% trypsin-EDTA to maintain 70–80% cellular
confluence.
After HTR8SVneo cells were plated in complete media for 24 hours, 2 experiments were
performed to simulate conditions of a) hypoxia and b) growth factor deprivation. For hypoxia,
HTR8SVneo cells were treated with cobalt chloride (CoCl2), a chemical mimetic of hypoxia
(Sigma-Aldrich, MO). We have chosen to administer cobalt chloride at concentrations of
250 μM and 500 μM, based on prior studies that tested COCl2-induced hypoxia in HTR8/
SVneo cells [32]. For growth factor deprivation, we incubated cells with serum-free media
(FBS is omitted). After 24 hours, cells were lysed in cold RIPA lysis buffer with a protease and
phosphatase inhibitor cocktail (Thermo Scientific/Pierce, IL), sonicated, and centrifuged at
4˚C. The cell lysates were analyzed by western blot to assess HN and GLUT8 expression.
RNA extraction and quantitative RT-PCR. Total RNA was extracted from human pla-
cental samples using Direct-zol RNA MiniPrep Kit (Zymo Research, CA). First-strand cDNA
was synthesized from 1 μg of total RNA using a qScript cDNA Synthesis Kit (Quanta Biosci-
ences, MD). cDNA was used to perform RT-PCR using RT2 SYBR Green (Qiagen, CA) and
GLUT8 primers (PPH13718A, Qiagen, CA). The cycling conditions consisted of 95˚C for 10
minutes, followed by 40 cycles at 95˚C for 30 seconds and 60˚C for 1 minute. Relative quantifi-
cation was used to calculate the difference between the target gene and the housekeeping gene
18S rRNA using the ΔCT method [33].
Western blot analysis. Human placental samples were lysed in radioimmunoprecipita-
tion assay buffer with a protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific)
on ice and centrifuged at 4˚C. Supernatants were assayed for protein content using a BCA Pro-
tein Assay Kit (Thermo Fisher Scientific). Equal concentrations of samples, 20 μg of human
placental tissue lysate protein were loaded onto 10% TGX gels (Bio-Rad, Hercules, CA) and
subjected to gel electrophoresis. Human normal brain cerebellum tissue lysate (Abcam, Cat. #
ab30069) was used as a positive control. The contents of the gels were transferred onto polyvi-
nylidene difluoride (PVDF) membranes using Trans-Blot1 Turbo™ Transfer System (Bio-
Rad). After blocking in 5% bovine serum albumin with 1× phosphate-buffered saline with
Tween-20, membranes were incubated with primary antibody GLUT8 (Abcam, Cat. #
ab169779) at 1:5000 dilution, and secondary antibody goat anti-rabbit IgG-horseradish peroxi-
dase (Santa Cruz Biotechnology, Cat. # sc-2030) at 1:10,000 dilution. Vinculin (Sigma-Aldrich,
Cat. # V4505) was used as a loading control at 1:30,000 dilution, and secondary antibody goat
anti-mouse IgG-horseradish peroxidase was used at 1:10,000 dilution. Immunoreactive signals
were analyzed using Pierce ECL Plus (Thermo Fisher Scientific) on a Typhoon Scanner 9410
(GE Healthcare Life Sciences, Pittsburgh, PA) through ImageQuant 5.2 software (GE Health-
care Life Sciences). The protein bands were quantified by densitometry using ImageJ software
(National Institutes of Health, MD).
Immunohistochemistry. Serial sections of the placenta of 4 μm were cut in the same
orientation from paraffin embedded tissue blocks and mounted onto Superfrost plus glass
microscope slides. The slides were deparaffinized in xylene and rehydrated in descending con-
centrations of alcohol. Endogenous peroxidase activity was blocked with hydrogen peroxide in
methanol for 10 minutes. Heat-induced antigen retrieval (HIER) was carried out for all sec-
tions in 0.01M Citrate buffer, pH = 6.00, using a Biocare decloaker at 95˚C for 25 min. The
slides were then cooled to RT, rinsed in PBS containing 0.05% Tween-20 (PBS-T), and incu-
bated overnight at 4˚C with anti-Humanin antibody (Sigma-Aldrich, Cat. # H2414) with nega-
tive control normal rabbit IgG (Santa Cruz, Cat. # sc-2027) at 1:50 and anti-GLUT8 antibody
(Abcam, Cat. # ab169779) with negative control Normal rabbit IgG (Santa Cruz, Cat. # sc-
HN and GLUT8 in IUGR
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2027) at 1:100 dilutions. They were then incubated for 1 hour at RT with anti-AE1/AE3 anti-
body (Dako, Cat. # M3515) with negative control normal mouse IgG (Santa Cruz, Cat. # sc-
2025) at 1:500 dilution and rabbit polyclonal Lysozyme (Agilent, cat. #A0099) with negative
control normal rabbit IgG (Santa Cruz, Cat. # sc-2027) at 1:1500 dilution. The sections were
then rinsed with PBS-T. The signal was detected using the rabbit horseradish peroxidase EnVi-
sion kit (Dako, Cat. # K4003) for Humanin, GLUT8 and Lysozyme [34]. Mouse horseradish
peroxidase EnVision kit (Dako, Cat. # K4001) was used for AE1/AE3 at RT for 30 minutes for
detection. The sections were next rinsed with PBS-T and incubated with DAB (3,3’-Diamino-
benzidine) for visualization. The sections were washed in H2O, counterstained with Harris’
Hematoxylin, dehydrated in EtOH, and cover slipped with mounting media.
Fluorescent immunohistochemistry. Non-specific binding was blocked on deparaffi-
nized slides with 0.2% Triton X-100 in 5% normal donkey serum and 1% gelatin at room tem-
perature (RT) for 1 hour. Sections were then incubated with anti-GLUT8 antibody (abcam,
Cat. # ab169779) at 1:20 and negative control normal rabbit IgG (Santa Cruz, Cat. # sc-2027)
at 1:20 at RT for 2 hours, followed by overnight incubation at 4˚C. Sections were washed thor-
oughly with 1x PBS and incubated with Texas red-conjugated donkey anti-rabbit secondary
antibody (Jackson Immunoresearch, Cat. # 711-295-152) at 1:500 and DAPI (4’,6-diamidino-
2-phenylindole dihydrochloride) antibody (Sigma, Cat. #D9542) at 1:1000 at RT for 1 hour.
The images were captured under a Nikon E-600 microscope (Nikon, NY), equipped with a
cooled charge-coupled device (CCD) camera (Cool SNAP HQ Monochrome, Roper Scientific,
AZ). To quantify GLUT8 expression, fluorescence images were observed. There were 5 control
and 5 IUGR placentas. There was 1 full thickness section for each placenta. 17–22 fields were
randomly selected for each section. Images were acquired at 12-bit gray level resolution and
displayed in pseudocolor (monochrome) for analysis with GLUT8 represented by Texas red-
conjugated donkey anti-rabbit secondary antibody (Jackson Immunoresearch, Cat. # 711-295-
152). The Metamorph image analysis system software (Molecular Devices, CA) was used to
measure integrated optical density for GLUT8 expression.
HTR8/SVneo cells were also fixed in 4% paraformaldehyde and washed with PBS. Cells
were incubated overnight at 4˚C with Anti-Humanin antibody (Sigma, Cat. #H2414) at 1:300
and Anti-GLUT8 antibody (Abcam, Cat. # ab169779) at 1:10 dilution. Normal rabbit IgG
(Santa Cruz, Cat. # sc-2027) was used with GLUT8 and Humanin as negative controls. The
fixed cells were next rinsed with PBS-T and subsequently incubated with a mixture of Alexa
Fluor 488-conjugated donkey anti-rabbit IgG (Jackson Immunoresearch, Cat. #711-545-152)
at 1:250 and DAPI (Sigma, Cat. #D9542) at 1:1000 in RT for 1 hour. The Nikon E-600 micro-
scope mounted with a cooled charge-coupled device (CCD) camera (CoolSnap HQ Mono-
chrome) was utilized to capture images under a fluorescence microscope at 40x magnification.
Immunoprecipitation (IP) assay. Immunoprecipitation was performed using Dynabeads
protein G Immunoprecipitation kit (Invitrogen, Vilnius, LT). 50ulit of Dynabead first incubate
with 10ugm of humanin (Sigma H2414) and GLUT8 (Ab 169779) separately with rotation at
room temperature for 2hrs. Rabbit non-isotype IgG was used as negative control. The beads
were then separated on the magnet and supernatant was removed. The beads–Ab complex
were washed in PBS with Tween 20, then 300ugm of protein lysate were added to the washed
beads and allow them to bind the antigen with Dynabeads–Ab complexes overnight at 4˚C
with rotation. Next the beads were separated by magnet and washed the Dynabeads Ab-Ag
complexes using washing buffer, finally the beads were boiled with 4xSDS sample loading
buffer at 95˚C for 5 minutes, and the samples were analyzed by western blot.
Human primary villous trophoblast cells (ScienCell, Cat. # 7120) were cultured in tropho-
blast medium (ScienCell, Cat. #7121) with trophoblast growth supplement (ScienCell, Cat.
#7152) and 1% penicillin-streptomycin solution (ScienCell, Cat. #0503) in an incubator with
HN and GLUT8 in IUGR
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an atmosphere of 5% CO2/95% air. The cells were cultured in the media both with 5% fetal
bovine serum and without fetal bovine serum for 8 hours and 24 hours. After 8 and 24 hours,
cells were fixed in 4% paraformaldehyde and washed with PBS. Cells were incubated overnight
at 4˚C with anti-Humanin antibody (Sigma, Cat. #H2414) at 1:300 and anti-GLUT8 antibody
(Abcam, Cat. # ab169779) at 1:10 dilution. Normal rabbit IgG (Santa Cruz, Cat. # sc-2027)
was used for GLUT8 with Humanin as negative control. The fixed cells were next rinsed with
PBS-T and subsequently incubated with a mixture of Alexa Fluor 488-conjugated donkey anti-
rabbit IgG (Jackson Immunoresearch, Cat. #711-545-152) at 1:250 and DAPI (Sigma, Cat.
#D9542) in RT for 1 hour. The Nikon E-600 microscope mounted with a cooled charge-cou-
pled device (CCD) camera (CoolSnap HQ Monochrome) was utilized to capture images under
a fluorescence microscope at 40x magnification. 2–4 fields were randomly selected for each
sample. Images were acquired at 12-bit gray level resolution and displayed in pseudocolor
(monochrome) for analysis with GLUT8 and Humanin represented by Alexa Fluor 488-conju-
gated donkey anti-rabbit IgG (Jackson Immunoresearch, Cat. #711-545-152). The Metamorph
image analysis system software (Molecular Devices, CA) was used to measure integrated opti-
cal density for GLUT8 and Humanin expression.
Data analysis
For mRNA and Western blot analyses, the integrated band density readout in arbitrary densi-
tometric units was normalized based on control samples (i.e. value of 100%) for each experi-
mental set of conditions. Statistical analysis was performed using SigmaStat 3.5 and StatView
5.0 softwares. We checked normality assumption of the raw data and if it was not violated, we
used Student’s t test (if 2 groups) or ANOVA (if >2 groups) in group comparisons. When
more than 2 groups were involved in the comparison and there was an overall statistically sig-
nificant difference, we did pairwise comparisons using Tukey’s type I error (set at 5%) adjust-
ment method in order to control for the inflation of Type I error. Type I error rate can inflate
when you do multiple comparisons (ie pairwise comparisons). If the data was not normally
distributed, we used nonparametric methods such as Wilcoxon rank sum test (Student t test
analog) or Kruskal Wallis teat (ANOVA analogue). In testing the main effects of time and
treatment and timetreatment interaction, we performed 2-way ANOVA incorporating the
interaction term. All data are shown as mean±SEM, and statistical significance was assigned at
p<0.05. Different p-value cutoff scores were indicated as following:  = p<0.05,  = p<0.01,
 = p<0.001, and  = p<0.0001.
Results
mRNA and protein levels of GLUT8 are increased in IUGR-affected
pregnancies
mRNA and protein expression of GLUT8 on the fetal and maternal aspects of the placenta
from IUGR-affected and normal pregnancies are shown in Fig 1. GLUT8 mRNA levels were
increased significantly by nearly 13-fold in the IUGR samples on the maternal aspect of the
placenta versus control samples (Fig 1A). A significant difference in GLUT8 mRNA expression
between maternal and fetal IUGR-affected placentas was detected as well. GLUT8 protein
expression was also increased on the maternal face of the placenta from IUGR-affected preg-
nancies compared to normal (Fig 1B). There were no appreciable differences observed on the
fetal side of the placenta.
GLUT8 immunofluorescence staining was subsequently performed in human IUGR-
affected and control placental samples to visualize GLUT8 cellular localization and expression
HN and GLUT8 in IUGR
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Fig 1. mRNA and protein levels of GLUT8 are increased in IUGR-affected pregnancies. (A) Real-time quantitative RT-PCR
analysis of placental GLUT8 expression. IUGR-affected placentas (n = 22) were assayed against gestational age-matched, control
placentas (n = 22) for the maternal and fetal sides. Relative quantification of PCR products was based on the CT value differences
between target and the housekeeping gene using the comparative CT method (Eukaryotic 18S rRNA) was used as an internal
control. ( = p<0.001). (B) Western blot analysis of GLUT8 in placental biopsies obtained from women with normal
HN and GLUT8 in IUGR
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differences. Fig 2 shows increased expression of GLUT8 in IUGR-affected placenta by immu-
nofluorescence. Quantitation of the staining shows a 7-fold elevation in the expression of
GLUT8 protein in the IUGR-affected placenta compared to control seen in Fig 2B.
HN expression is increased in IUGR-affected pregnancies
We next performed immunohistochemical staining in human placenta to determine HN
expression. We did not measure mRNA levels of HN since the location of the gene (or genes)
encoding the HN peptide has not been determined conclusively [35]; there are more than 10
putative transcription sites for the endogenous HN peptides encoded by the MT-RNR2-like
nuclear genes. Fig 3A shows that HN is expressed in extravillous trophoblasts (EVTs) in the
maternal decidua and also in EVTs on the maternal surface of the placenta. This expression
was increased in IUGR-affected placenta compared to control. Fig 3B shows HN and GLUT8
expression in serial sections of a control placenta (38 weeks). In order to label trophoblast cells
(EVT in the decidua and the maternal surface of the placenta), we used anti-cytokeratin cock-
tail AE1/AE3 (left panel). There is significant overlap between the cells (trophoblasts) that
stain positive for both HN and GLUT8. Cell staining with lysosomal marker reveals granular
cytoplasmic staining of decidual stroma and maternal surface EVTs in a similar distribution of
trophoblast cells.
In vitro trophoblast cell studies
Confirmation of HN and GLUT8 interaction. In order to study whether HN and
GLUT8 are proteins that interact in vivo, we performed coimmunoprecipitation (coIP) in a
well-established human EVT cell line, HTR8/SVneo human trophoblasts. Fig 4 shows that
coIP of HN and GLUT8 confirmed an in vitro interaction. First endogenous GLUT8 protein
was immunoprecipitated from HTR8/SVneo cells with either non-istotype IgG (negative con-
trol) or GLUT8 antibody (left panel). The precipitates were subjected to western immunoblot
analysis with anti-HN antibody. As shown in Fig 4A, humanin precipitates with GLUT8.
Inversely, GLUT8 precipitates with HN (Fig 4B).
Cytoplasmic localization of HN and GLUT8 in human extravillous trophoblastic
cells. To determine nuclear vs. cytoplasmic staining of HN and GLUT8 in human tropho-
blasts, we performed immunohistochemistry in HTR8/SVneo cells (Fig 5). Two representative
fields (A and B) of untreated cells are shown at 40x magnification. Fig 5A shows similar immu-
nolocalization of HN (green) and DAPI (blue), and Fig 5B shows similar immunolocalization
of GLUT8 (green) and DAPI (blue). HN and GLUT8 both positively stained predominantly in
the cytoplasm. This result supports localization of HN in the human placental system.
Increased HN and GLUT8 expression in HTR8/SVneo cells with CoCL2. In order to
simulate conditions of hypoxic stress, we administered, cobalt chloride (CoCl2), a chemical
mimetic of hypoxia [32], to HTR8/SVneo cells, in order to observe the effect on the expression
of HN and GLUT8 (Fig 6A). Hypoxia was confirmed by heightened expression of hypoxia
inducible factor-1α (HIF-1α). Incubation of human EVT cells with 500 μM CoCl2 for 4 hours
resulted in a peak 1.7-fold induction of HN with decreasing levels by 24 hours (Fig 6A-1).
pregnancy (n = 22) or IUGR-affected pregnancy, by abnormal prenatal ultrasound (n = 22). Vinculin was used as the loading
control. Representative blots are shown. ( = p<0.01). The arrow pointing at the dark band at approximately 130 kDa indicates
Vinculin. The arrow pointing at the dark band at approximately 51 kDa indicates GLUT8. Sample label abbreviations are as
follows: "CM" is control maternal side, "CF" is control fetal side, "IM" is IUGR maternal side, and "IF" is IUGR fetal side. The
number following the sample abbreviation indicates sample ID. The same number on multiple labels indicates the same sample.
Brain was used as a positive control for GLUT8.
https://doi.org/10.1371/journal.pone.0193583.g001
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Fig 2. Increased immunofluorescence of GLUT8 in IUGR-affected placentas. (A) Immunoflourescence staining of GLUT8 (red) and DAPI (blue) of
placental tissue. Left: negative control performed with non-isotype IgG to measure the level of non-specific background signal. Middle: GLUT8 staining in
the normal placenta. Right: GLUT8 staining of the IUGR-affected placenta. Plus sign (+) indicates intervillous space. Asterisk () shows villous core. Line
arrows show syncytiotrophoblast. Hollow arrows show cytotrophoblast. All images taken at 40X magnification. (B) Relative quantitation of GLUT8
immunofluorescence staining of GLUT8 in the normal and IUGR-affected human placenta. ( = p<0.05). Images were captured with Nikon E-600
HN and GLUT8 in IUGR
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GLUT8 levels increased after incubation with CoCl2, which is used to mimic hypoxic condi-
tions, with a delayed peak of a 2.9-fold rise after 8 hours with decreasing levels after 24 hours
(Fig 6A-2). Therefore, CoCl2 addition results in a time and dose-dependent elevation in the
levels of GLUT8 with an overall delayed and prolonged effect compared to the changes in HN
expression under the same experimental conditions.
HTR8/SVneo cells under serum starvation experience up-regulation of HN but attenua-
tion of GLUT8 expression. Growth factor deprivation in HTR8/SVneo cells was also consid-
ered to examine another condition associated with IUGR. This condition was mimicked by
treatment with serum-free growth medium, and these cells were compared with their serum-
supplemented (10% FBS) counterparts at 8, 24, and 48 hours (Fig 6B). There was a 1.8-fold
increase in HN expression after 8 hours of serum deprivation compared to controls (Fig 6B-1).
Conversely, serum deprivation results in a significant reduction in GLUT8 expression—one-
third (29%) and 4-fold after 24 hours and 48 hours, respectively, compared to control groups
(Fig 6B-2). Thus, unlike CoCl2 treatment, serum deprivation has a delayed effect and results in
decreased GLUT8 expression.
Evaluation of GLUT8 and HN expression in primary human trophoblasts exposed to
serum starvation. To examine the effect of growth factor deprivation on the expression of
HN and GLUT8, we grew primary human trophoblasts in culture with and with out serum for
24 hours. Representative photomicrographs with HN and GLUT8-specific fluorescence are
shown in Fig 7. Similar to HTR8/SVneo cells, we found with serum deprivation, there was a
trend towards increased HN expression but decreased GLUT8 without serum at 8 and 24
hours.
Discussion
In this study we show, for the first time, that HN is expressed in the human placenta, and that
there is increased HN and GLUT8 expression on the maternal aspect of the placenta in preg-
nancies affected by idiopathic IUGR. HN has demonstrated cytoprotection in multiple aging-
related and neurologic disease processes, including Alzheimer’s disease [9, 36, 37], conditions
of memory loss [38], cardiovascular disease [6, 39], type 1 diabetes [40], and stroke [41]. A
pathophysiologic mechanism common to many of these diseases is oxidative stress, which also
occurs during normal and abnormal pregnancies [42–46]. A physiological level of oxidative
stress and nutrient transport is required for proper embryonic and fetal growth [45]. However,
an altered degree of oxidative stress and nutrient exchange in the intrauterine environment
becomes problematic and is linked to complications of pregnancy such as maternal vascular
disease, gestational diabetes, placental insufficiency, and pre-eclampsia [3]. In particular,
increased oxidative stress induced by hypoxia-ischemia is suggested to lead to IUGR of the
developing fetus and associated metabolic diseases subsequently throughout life [1–3].
Many studies on exogenous administration of HN have shown that it mitigates oxidative
stress-associated apoptosis and improves tissue functions in non-placental systems [5–8, 47].
No previous investigations, however, have examined HN expression in human placentas.
Interestingly, a recent study has shown elevated levels of HN in the human sera of pre-eclamp-
tic pregnancies versus normal pregnancies, suggesting a role of HN during pregnancy [15].
These studies provided the rationale to examine HN in placental pathology.
microscope (Nikon, NY), equipped with a cooled charge-coupled device (CCD) camera (Cool SNAP HQ Monochrome, Roper Scientific, AZ). There were 5
control and 5 IUGR placentas, full thickness section for each placenta. 20 fields were randomly selected for each section. Images were acquired at 12-bit
gray level resolution and displayed in psuedocolor (monochrome) for analysis with GLUT8 represented by Alexa Fluor 488-conjugated donkey anti-rabbit
IgG. The Metamorph image analysis system software (Molecular Devices, CA) was used to measure integrated optical density for GLUT8 expression.
https://doi.org/10.1371/journal.pone.0193583.g002
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Fig 3. Increased immunohistochemical staining of HN in IUGR-affected placentas. (A) Immunohistochemical staining of humanin (HN) in human
placental tissue at gestational age of 38 weeks. Humanin was stained in brown. The left column shows staining of the stem villi EVT of placental tissue, and
the right column shows staining of the maternal surface EVT of placental tissue. The top row of both columns is negative control performed with non-isotype
IgG. The middle row of both columns is placenta from normal pregnancies. The bottom row of both columns is IUGR. 40x magnification for all images. (B)
Immunohistochemical staining in normal (control) human placental tissue showing four different markers of same placental sample (serial sections) at 38
HN and GLUT8 in IUGR
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Conversely, GLUT8 is a dual-specificity glucose and fructose transporter, which varies in
its localization and function depending on the tissue in which it is expressed [27, 48]. GLUT8
participates in insulin-stimulated cell-membrane translocation from an intracellular vesicular
compartment, for hexose transport only in the blastocyst [27]. In other cell types including the
brain [49, 50], however, GLUT8 is involved exclusively in intracellular hexose transport with
no evidence of membrane localization [51]. This tethering of GLUT8 within intracellular vesi-
cles is due to the presence of a di-leucine motif, abrogation of which lends the ability to trans-
locate to the plasma membrane [50]. This intracellular organelle location of GLUT8 may be
responsible for fueling the mitochondrial machinery and interplay with HN, since this cyto-
plasmic location of GLUT8 closely mimics the HN localization described previously in human
skeletal muscles [52]. Despite a large number of studies on HN and GLUT8, no studies have
examined the co-localization of HN and GLUT8 in human IUGR-associated conditions.
Therefore, our study examined both HN and GLUT8 expression simultaneously in an attempt
to determine their relationship in normal and IUGR-affected placentas.
Our results show that the human placenta affected by idiopathic late-term IUGR exhibits
variable expression of GLUT8, which is increased on the maternal aspect of the placenta, but
unchanged on the fetal aspect of the placenta. These results are similar to our previous findings
for GLUT3 [26], which also showed a similar expression profile in IUGR. Increased placental
GLUT8 levels were associated with increased HN expression levels, suggesting that HN and
GLUT8 may share a similar regulatory mechanism for expression in IUGR. Both HN and
GLUT8 demonstrated cytoplasmic localization to extravillous trophoblasts (EVTs) on the
weeks gestational age. The top row is the non-isotype IgG control for each of the markers labeled. The bottom row from left to right is staining of AE1/AE3
(trophoblast marker), GLUT8, Humanin, and lysozyme (lysosomal marker). The presence of EVT on the right portion of each image is supported by diffuse
cytoplasmic staining of AE1/AE3, while the endometrial stromal cells within the decidua on the left portion of each image are negative for AE1/AE3. Each of
the four images on the bottom row shows the decidua on the left side and maternal surface EVT on the right side of the image. Arrows point to maternal
surface EVT and triangles indicate decidual stromal cells. All images were taken at 20x magnification.
https://doi.org/10.1371/journal.pone.0193583.g003
Fig 4. Immunoprecipitation (IP) assays reveal association between endogenous humanin with Glut8 in HTR-8 cells. (A) HTR8/SVneo protein was
immunoprecipitated with Glut8 antibody then the bound protein was analyzed by western blot with humanin antibody. (B) HTR8/SVneo protein lysate was
immunoprecipitated with humanin antibody then analyzed by western blot with glut8 antibody. In both the cases Rabbit non-isotype IgG was used as negative
control (-C) and in positive control (+C), both the immunoprecipitation and western blot analyses were done using the same antibody (either humanin or Glut8
antibody).
https://doi.org/10.1371/journal.pone.0193583.g004
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maternal aspect. Given this localization pattern, we also evaluated isolated EVTs in vitro and
found that both HN and GLUT8 displayed similar localization patterns with cytoplasmic dis-
tribution of these two proteins. To evaluate interaction between HN and GLUT8, we next
undertook co-immunoprecipitation experiments, revealing protein-protein binding, suggest-
ing a role for HN and GLUT8 working together.
To further pinpoint the inciting factor(s) that up-regulate(s) HN in human IUGR-affected
placentas, we next employed in vitro strategies with HTR8/SVneo human EVT cell cultures.
Since EVT plays a key role in early implantation events, we subjected them to two non-physio-
logic, oxidative stress-associated conditions that have been correlated with IUGR [53, 54]: (1)
persistent placental hypoxia (associated with poor trophoblast invasion and reduced utero-
placental perfusion [2, 3], and (2) maternal growth factor restriction (associated with dimin-
ished trans-placental glucose transport and gene expression profiles seen in IUGR phenotypes)
[55]. Under these conditions, EVTs demonstrate a cytoplasmic localization of both HN and
GLUT8. However, their protein expression profiles displayed up-regulation of HN and
GLUT8 under chemically stimulated hypoxia, but only HN expression was elevated in growth
factor restriction while GLUT8 expression was reduced. Thus, one may surmise that hypoxia
may be necessary for inducing GLUT8, but growth factor restriction or hypoxia alone both
up-regulate HN. Therefore, our current finding of increased HN and GLUT8 in IUGR-
affected placental EVTs suggests a major role for uteroplacental insufficiency-induced hypoxia
as the inciting factor. Both HN and GLUT8 have previously been induced under in vitro hyp-
oxic conditions [16, 17] in other cell types, lending credence to our present in vivo observa-
tions. The time-dependent studies revealed that HN expression elevation occurred acutely at 4
hours of hypoxia while GLUT8 increased at 8 hours, subsequent to the change in HN. This
Fig 5. Immunocytochemical staining showing localization of HN and GLUT8 in HTR8/SVneo cells. The top rows show localization of GLUT8. On the top row, the
left image is the non-isotype IgG control, the left middle is GLUT8 (green) staining taken using a filter for GLUT8 alone, the right middle is DAPI (blue) taken using a
filter for DAPI alone, and the right image is GLUT8 (green) and DAPI (blue) combined. The 3 rightmost images are of the same area. The bottom rows show images of
humanin. On the bottom row, the left image is the non-isotype IgG control, the left middle is Humanin (green) staining using a filter for Humanin alone, the right
middle is DAPI (blue) using a filter for DAPI alone, and the right image is Humanin (green) and DAPI (blue) combined. The three rightmost images are of the same
area. All images have 40x magnification. Scale bar = 50 μm.
https://doi.org/10.1371/journal.pone.0193583.g005
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Fig 6. CoCl2-stimulated hypoxia induces HN and GLUT8 expression in HTR8/SVneo cells, and serum-deprived HTR8/SVneo cells up-regulates HN
levels but down-regulates GLUT8 levels. (A) HN and GLUT8 levels were determined by Western blot analysis at 4, 8, and 24 hours of incubation of
HTR8/SVneo cells in 250 and 500 μM CoCl2–supplemented complete media. Representative blots are shown. β-actin and vinculin were used as loading
controls for HN and GLUT8, respectively (n = 3,  = p<0.05,  = p<0.01, and  = p<0.001). (B) HN and GLUT8 expression was also monitored in
HTR8/SVneo cells at 8, 24 and 48 hours of cultivation in serum-supplemented (FBS (+)) and serum-free media (FBS (-)). Representative blots are shown. β-
actin and vinculin were used as the loading controls for HN and GLUT8, respectively. (n = 3,  = p<0.05 and  = p<0.01).
https://doi.org/10.1371/journal.pone.0193583.g006
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observation supports the paradigm that HN increase precedes the GLUT8 increase that may
be necessary for the biologic role of GLUT8 in transporting intracellular glucose to organelles
necessary to fuel mitochondrial energy metabolism. In addition to the EVTs alone, primary
cultures of human trophoblasts also revealed a similar effect of serum starvation, suggesting a
similar effect beyond the EVTs alone. Studies of the subcellular localization of GLUT8 indicate
that GLUT8, found on the membrane of the endoplasmic reticulum (ER), may play a role in
glucose transport between the cytosol and intracellular organelles [51]. Indeed, in GLUT8
knockout mice, GLUT8 deletion resulted in impaired mitochondria function in sperm cells
and a 50% decrease in ATP production [56]. Further, GLUT8 deletion (-/-) caused a reduction
in murine litter size and pup size due to impaired decidualization and implantation [57], sup-
porting a functional role for the presence of GLUT8 in extravillous trophoblasts.
Although several papers have already shown HN localization in tissues such as hippocam-
pus [36], skeletal muscles [52], and testes [58], this original article presents for the first time
the presence of endogenous HN in human placenta. Our present observations are also the
first-of-a-kind to examine interplay between placental HN and GLUT8 and demonstrate a
potential relationship given their similar sub-cellular localization, protein-protein interaction,
and expression. We speculate, based on the data presented in this report, that HN and GLUT8
play a protective role in governing the physiological adaptations required of the IUGR-affected
placenta to ensure survival within an adverse intrauterine environment. Further studies are
necessary to elucidate their physical interactions and the molecular and cellular mechanisms
that govern these interactions in normal and IUGR-affected placentas.
Conclusions
In summary, we have established the sub-cellular cytoplasmic presence of HN and GLUT8 in
human placental EVTs found on the maternal aspect, and demonstrated an up-regulation in
Fig 7. Primary human trophoblasts exposed to serum starvation. Top row is GLUT8 staining (green) of human primary villous trophoblast cells. Bottom row is
humanin staining (green) of human primary villous trophoblast cells. All images show DAPI staining of nuclei (blue). From left to right: non-isotype IgG control, cells
grown for 8 hours with serum, cells grown for 8 hours without serum, cells grown for 24 hours with serum, cells grown for 24 hours without serum. All images taken at
40x magnification. Scale bar = 50 μm.
https://doi.org/10.1371/journal.pone.0193583.g007
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IUGR. In addition to this novel finding, we have established with the help of in vitro EVT cell
cultures, that while simulated hypoxia regulates both HN and GLUT8, only growth factor
restriction increased HN. Most importantly a protein-protein interaction between HN and
GLUT8 suggests that their interaction may fulfill a biologic role that requires interdependency.
Future investigations delineating molecular interactions between these proteins are required
to fully uncover their role in IUGR-affected pregnancies.
Supporting information
S1 Fig. Original western blots. Original uncropped and unadjusted western blots used to cre-
ate Fig 6 in manuscript are provided here as labeled.
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